Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Association between the trajectory of ideal cardiovascular health metrics and incident chronic kidney disease among 27,635 older adults in northern China–a prospective cohort study

Authors: Pufei Bai, Xian Shao, Xiaoqun Ning, Xi Jiang, Hongyan Liu, Yao Lin, Fang Hou, Yourui Zhang, Saijun Zhou, Pei Yu

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

There is a lack of relevant studies evaluating the long-term impact of cardiovascular health factor (CVH) metrics on chronic kidney disease (CKD).

Objective

This study investigates the long-term change in CVH metrics in older people and explores the relationship between CVH metrics trajectory and CKD.

Methods

In total, 27,635 older people aged over 60 from the community-based Tianjin Chronic Kidney Disease Cohort study were enrolled. The participants completed five annual physical examinations between January 01, 2014, and December 31, 2018, and a subsequent follow-up between January 01, 2019, and December 31, 2021. CVH metrics trajectories were established by the group-based trajectory model to predict CKD risk. The relationships between baseline CVH, CVH change (ΔCVH), and CKD risk were also explored by logistic regression and restricted cubic spline regression model. In addition, likelihood ratio tests were used to compare the goodness of fit of the different models.

Results

Six distinct CVH metrics trajectories were identified among the participants: low-stable (11.19%), low-medium-stable (30.58%), medium-stable (30.54%), medium-high-decreased (5.46%), medium-high-stable (18.93%), and high-stable (3.25%). After adjustment for potential confounders, higher CVH metrics trajectory was associated with decreased risk of CKD (P for trend < 0.001). Comparing the high-stable with the low-stable group, the risk of CKD decreased by 46%. All sensitivity analyses, including adjusting for baseline CVH and removing each CVH component from the total CVH, produced consistent results. Furthermore, the likelihood ratio test revealed that the model established by the CVH trajectory fit better than the baseline CVH and Δ CVH.

Conclusion

The higher CVH metrics trajectory and improvement of CVH metrics were associated with decreased risk of CKD. This study emphasized the importance of improving CVH to achieve primary prevention of CKD in older people.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15.CrossRefPubMed Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15.CrossRefPubMed
2.
go back to reference Tonelli M, Riella M. Chronic kidney disease and the aging population. Am J Nephrol. 2014;39(3):248–51.CrossRefPubMed Tonelli M, Riella M. Chronic kidney disease and the aging population. Am J Nephrol. 2014;39(3):248–51.CrossRefPubMed
3.
go back to reference Wang F, He K, Wang J, Zhao MH, Li Y, Zhang L, et al. Prevalence and risk factors for CKD: a comparison between the adult populations in China and the United States. Kidney Int Rep. 2018;3(5):1135–43.CrossRefPubMedPubMedCentral Wang F, He K, Wang J, Zhao MH, Li Y, Zhang L, et al. Prevalence and risk factors for CKD: a comparison between the adult populations in China and the United States. Kidney Int Rep. 2018;3(5):1135–43.CrossRefPubMedPubMedCentral
4.
go back to reference Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2008;51(3):373–84.CrossRef Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2008;51(3):373–84.CrossRef
5.
go back to reference McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrology: JASN. 2019;30(1):127–35.CrossRefPubMed McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrology: JASN. 2019;30(1):127–35.CrossRefPubMed
6.
go back to reference Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.CrossRefPubMed Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.CrossRefPubMed
7.
go back to reference Huffman MD, Capewell S, Ning H, Shay CM, Ford ES, Lloyd-Jones DM. Cardiovascular health behavior and health factor changes (1988–2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation. 2012;125(21):2595–602.CrossRefPubMedPubMedCentral Huffman MD, Capewell S, Ning H, Shay CM, Ford ES, Lloyd-Jones DM. Cardiovascular health behavior and health factor changes (1988–2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation. 2012;125(21):2595–602.CrossRefPubMedPubMedCentral
8.
go back to reference Cho SMJ, Jeon JY, Yoo TH, Lee HY, Lee YH, Kim HC. Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease. Heart. 2021. Cho SMJ, Jeon JY, Yoo TH, Lee HY, Lee YH, Kim HC. Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease. Heart. 2021.
9.
go back to reference Hou J, Li J, Huang J, Lu C, Zhou J, Liu Y, et al. Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-the Kailuan study. PLoS ONE. 2018;13(8):e0203171.CrossRefPubMedPubMedCentral Hou J, Li J, Huang J, Lu C, Zhou J, Liu Y, et al. Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-the Kailuan study. PLoS ONE. 2018;13(8):e0203171.CrossRefPubMedPubMedCentral
10.
go back to reference KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4s):1–s115. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4s):1–s115.
11.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral
12.
go back to reference Gaye B, Canonico M, Perier MC, Samieri C, Berr C, Dartigues JF, et al. Ideal Cardiovascular Health, Mortality, and vascular events in Elderly subjects: the three-city study. J Am Coll Cardiol. 2017;69(25):3015–26.CrossRefPubMed Gaye B, Canonico M, Perier MC, Samieri C, Berr C, Dartigues JF, et al. Ideal Cardiovascular Health, Mortality, and vascular events in Elderly subjects: the three-city study. J Am Coll Cardiol. 2017;69(25):3015–26.CrossRefPubMed
13.
go back to reference Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, et al. Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44(7):1909–14.CrossRefPubMed Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, et al. Life’s simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44(7):1909–14.CrossRefPubMed
14.
go back to reference Ogunmoroti O, Oni E, Michos ED, Spatz ES, Allen NB, Rana JS et al. Life’s Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Association. 2017;6(6). Ogunmoroti O, Oni E, Michos ED, Spatz ES, Allen NB, Rana JS et al. Life’s Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Association. 2017;6(6).
15.
go back to reference Garg PK, O’Neal WT, Chen LY, Loehr LR, Sotoodehnia N, Soliman EZ et al. American Heart Association’s Life Simple 7 and Risk of Atrial Fibrillation in a Population Without Known Cardiovascular Disease: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Association. 2018;7(8). Garg PK, O’Neal WT, Chen LY, Loehr LR, Sotoodehnia N, Soliman EZ et al. American Heart Association’s Life Simple 7 and Risk of Atrial Fibrillation in a Population Without Known Cardiovascular Disease: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Association. 2018;7(8).
16.
go back to reference Akinyelure OP, Sakhuja S, Colvin CL, Clark D 3rd, Jaeger BC, Hardy ST et al. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study. Hypertension (Dallas, Tex: 1979). 2020;76(6):1953-61. Akinyelure OP, Sakhuja S, Colvin CL, Clark D 3rd, Jaeger BC, Hardy ST et al. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study. Hypertension (Dallas, Tex: 1979). 2020;76(6):1953-61.
17.
go back to reference Lin Y, Zhou S, Liu H, Cui Z, Hou F, Feng S, et al. Risk analysis of Air Pollution and Meteorological factors affecting the incidence of diabetes in the Elderly Population in Northern China. J Diabetes Res. 2020;2020:3673980.CrossRefPubMedPubMedCentral Lin Y, Zhou S, Liu H, Cui Z, Hou F, Feng S, et al. Risk analysis of Air Pollution and Meteorological factors affecting the incidence of diabetes in the Elderly Population in Northern China. J Diabetes Res. 2020;2020:3673980.CrossRefPubMedPubMedCentral
18.
go back to reference Chevli PA, Mehta A, Allison M, Ding J, Nasir K, Blaha MJ et al. Relationship of American Heart Association’s Life Simple 7, Ectopic Fat and Insulin Resistance in 5 racial/ethnic groups. J Clin Endocrinol Metab. 2022. Chevli PA, Mehta A, Allison M, Ding J, Nasir K, Blaha MJ et al. Relationship of American Heart Association’s Life Simple 7, Ectopic Fat and Insulin Resistance in 5 racial/ethnic groups. J Clin Endocrinol Metab. 2022.
19.
go back to reference Evans CR, Hong CP, Folsom AR, Heckbert SR, Smith NL, Wiggins K et al. Lifestyle moderates genetic risk of venous thromboembolism: the ARIC Study. Arteriosclerosis, thrombosis, and vascular biology. 2020;40(11):2756–63. Evans CR, Hong CP, Folsom AR, Heckbert SR, Smith NL, Wiggins K et al. Lifestyle moderates genetic risk of venous thromboembolism: the ARIC Study. Arteriosclerosis, thrombosis, and vascular biology. 2020;40(11):2756–63.
20.
go back to reference Corlin L, Short MI, Vasan RS, Xanthakis V. Association of the Duration of Ideal Cardiovascular Health through Adulthood with Cardiometabolic outcomes and Mortality in the Framingham offspring study. JAMA Cardiol. 2020;5(5):549–56.CrossRefPubMed Corlin L, Short MI, Vasan RS, Xanthakis V. Association of the Duration of Ideal Cardiovascular Health through Adulthood with Cardiometabolic outcomes and Mortality in the Framingham offspring study. JAMA Cardiol. 2020;5(5):549–56.CrossRefPubMed
21.
go back to reference Chung RJ, Mackie AS, Baker A, de Ferranti SD. Cardiovascular Risk and Cardiovascular Health behaviours in the transition from childhood to Adulthood. Can J Cardiol. 2020;36(9):1448–57.CrossRefPubMed Chung RJ, Mackie AS, Baker A, de Ferranti SD. Cardiovascular Risk and Cardiovascular Health behaviours in the transition from childhood to Adulthood. Can J Cardiol. 2020;36(9):1448–57.CrossRefPubMed
22.
go back to reference Liu K, Daviglus ML, Loria CM, Colangelo LA, Spring B, Moller AC, et al. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the coronary artery Risk Development in (Young) adults (CARDIA) study. Circulation. 2012;125(8):996–1004.CrossRefPubMedPubMedCentral Liu K, Daviglus ML, Loria CM, Colangelo LA, Spring B, Moller AC, et al. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the coronary artery Risk Development in (Young) adults (CARDIA) study. Circulation. 2012;125(8):996–1004.CrossRefPubMedPubMedCentral
23.
go back to reference Wu S, An S, Li W, Lichtenstein AH, Gao J, Kris-Etherton PM, et al. Association of Trajectory of Cardiovascular Health Score and Incident Cardiovascular Disease. JAMA Netw Open. 2019;2(5):e194758.CrossRefPubMedPubMedCentral Wu S, An S, Li W, Lichtenstein AH, Gao J, Kris-Etherton PM, et al. Association of Trajectory of Cardiovascular Health Score and Incident Cardiovascular Disease. JAMA Netw Open. 2019;2(5):e194758.CrossRefPubMedPubMedCentral
24.
go back to reference Zhang R, Xie J, Yang R, Li R, Chong M, Zhang X, et al. Association between ideal cardiovascular health score trajectories and arterial stiffness: the Kailuan Study. Hypertens Res. 2020;43(2):140–7.CrossRefPubMed Zhang R, Xie J, Yang R, Li R, Chong M, Zhang X, et al. Association between ideal cardiovascular health score trajectories and arterial stiffness: the Kailuan Study. Hypertens Res. 2020;43(2):140–7.CrossRefPubMed
25.
go back to reference Bakshi A, Jefferis J, Wolfe R, Wetmore JB, McNeil JJ, Murray AM, et al. Association of polygenic scores with chronic kidney disease phenotypes in a longitudinal study of older adults. Kidney Int. 2023;103(6):1156–66.CrossRefPubMed Bakshi A, Jefferis J, Wolfe R, Wetmore JB, McNeil JJ, Murray AM, et al. Association of polygenic scores with chronic kidney disease phenotypes in a longitudinal study of older adults. Kidney Int. 2023;103(6):1156–66.CrossRefPubMed
26.
go back to reference Garegnani L, Franco JVA, Escobar Liquitay CM, Brant LCC, Lim HM, de Jesus Jessen NP, et al. Cardiovascular health metrics in low and middle-income countries: a scoping review. Prev Med. 2023;172:107534.CrossRefPubMed Garegnani L, Franco JVA, Escobar Liquitay CM, Brant LCC, Lim HM, de Jesus Jessen NP, et al. Cardiovascular health metrics in low and middle-income countries: a scoping review. Prev Med. 2023;172:107534.CrossRefPubMed
27.
go back to reference Kaneko H, Itoh H, Kamon T, Fujiu K, Morita K, Michihata N, et al. Association of Cardiovascular Health Metrics with subsequent Cardiovascular Disease in Young adults. J Am Coll Cardiol. 2020;76(20):2414–6.CrossRefPubMed Kaneko H, Itoh H, Kamon T, Fujiu K, Morita K, Michihata N, et al. Association of Cardiovascular Health Metrics with subsequent Cardiovascular Disease in Young adults. J Am Coll Cardiol. 2020;76(20):2414–6.CrossRefPubMed
28.
go back to reference DeCoste LR, Wang N, Palmisano JN, Mendez J, Hoffmann U, Benjamin EJ, et al. Adherence to Ideal Cardiovascular Health Metrics is Associated with reduced odds of hepatic steatosis. Hepatol Commun. 2021;5(1):74–82.CrossRefPubMed DeCoste LR, Wang N, Palmisano JN, Mendez J, Hoffmann U, Benjamin EJ, et al. Adherence to Ideal Cardiovascular Health Metrics is Associated with reduced odds of hepatic steatosis. Hepatol Commun. 2021;5(1):74–82.CrossRefPubMed
Metadata
Title
Association between the trajectory of ideal cardiovascular health metrics and incident chronic kidney disease among 27,635 older adults in northern China–a prospective cohort study
Authors
Pufei Bai
Xian Shao
Xiaoqun Ning
Xi Jiang
Hongyan Liu
Yao Lin
Fang Hou
Yourui Zhang
Saijun Zhou
Pei Yu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04760-5

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine